We now know that long term infection with certain types of Human Papillomavirus (HPV) is the main cause of cervical cancer. Overseas research has shown that a test for these HPV types is, in fact, a better cervical cancer screening test than the Pap smear.


Controlled Trial

Compass is a randomised controlled trial to compare 2.5-yearly cytology-based cervical screening with 5-yearly primary HPV screening in Australian women aged 25-69. As of April 2019, we have now completed and closed recruitment in both categories: unvaccinated people and people aged between 25-36 years.
Compass is being carried out by the Australian Centre for the Prevention of Cervical Cancer in collaboration with The Daffodil Centre.

Get in touch

To find out more about what we do or how we can work together, please get in touch. 

Search our site